-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
August 17, 2020 // -- In a recent study published in the international journal PLOS ONE entitled "Impact of cardiovascular risk profile on COVID-19 outcome-A meta-analysis", scientists from Italy have found that cardiovascular risk factors may be closely related to complications and death risk in patients with COVID-19.
photo source: Sabatino et al, 2020 (PLOS ONE, CC BY 4.0) PATIENTs with co-existing cardiovascular disease or risk factors may be more likely to develop cardiovascular complications when hospitalized and more likely to die from COVID-19 infection; 19 can induce mild illness, however, it can induce serious pneumonia or even death in a particular population, so clinicians should probably also study patients with cardiovascular disease to understand the disease manifestations of patients with cardiovascular disease COVID-19 and the risk factors that induce COVID-19 infection.
the study, researchers analyzed data from 21 published observational studies involving 77,317 patients admitted to COVID-19 from Asia, Europe and the United States, 12.89 percent of patients (95 percent CI:8.24-18) when they were admitted. .32) At the same time, 36.08% of patients (95% CI:20.25-53.64) had high blood pressure and 19.45% (95% CI:12.55-27.45) had diabetes.
researchers said the incidence of cardiovascular disease was 14.09% (95% CI:10.26-20.23) during hospitalization in patients with COVID-19, with the most common complications being arrhyth arrhythmic or palpitations, and a significant number of patients When the researchers analyzed the data, they found that pre-existing cardiovascular complications or risk factors may be important predictive factors for cardiovascular complications (p=0.019), but age (p=0.197) and gender (p=0.173) may not be.
Finally, the researchers point out that age and pre-existing cardiovascular disease co-exist or risk factors may be important predictive factors for predicting death in patients with COVID-19, and that cardiovascular complications are common in the COVID-19 patient population and can lead to serious clinical events and even patient deaths.
original source: Sabatino J, De Rosa S, Di Salvo G, Indolfi C (2020) Impact of Cardiovascular risk profile on COVID-19 outcome. A meta-analysis. PLoS ONE 15 (8): e0237131. doi: 10.1371/journal.pone.0237131.
